aTyr Pharma (LIFE) IPO Opens Lower

Today's IPO for aTyr Pharma (NASDAQ: LIFE) opened for trading at $13.07 after pricing 5,360,000 shares of its common stock at an initial public offering price of $14.00 per share.

J.P. Morgan Securities LLC and Citigroup Global Markets Inc. are acting as joint book-running managers for the offering. BMO Capital Markets Corp. is acting as lead manager and William Blair & Company, L.L.C. is acting as co-manager.

aTyr Pharma is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of Physiocrine biology, a newly discovered set of physiological modulators. The Company's lead candidate, Resolaris™, is a first-in-class intravenous protein therapeutic for the treatment of rare myopathies with an immune component.

You May Also Be Interested In

• SpaceX prices IPO at $135 per share for June 12 Nasdaq debut
• Hedge funds sold broader tech ahead of SpaceX IPO, JPMorgan data shows
• Newly led Fed poses markets wildcard for rockier US indexes